Shuttle Pharmaceuticals (SHPH) Stock: Buy, Sell, or Hold?
SHPH - Shuttle Pharmaceuticals Holdings, Inc. Common Stock
$5.07
0.46 (9.93%)
â˛
5d:
-0.24%
30d:
+26.7%
90d:
+73.56%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 12, 2026
19d
Get Alerted When SHPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: SHPH is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: SHPH is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: SHPH is currently trading at $5.07, which is considered slightly high relative to its 30-day fair value range of $3.60 to $5.07.
Technical Outlook: Technically, SHPH is in a uptrend. Immediate support is located at $3.30, while resistance sits at $5.68. The stock is showing strong short-term momentum, up 9.9% recently.
Market Sentiment: SHPH scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SHPH is in a uptrend. Immediate support is located at $3.30, while resistance sits at $5.68. The stock is showing strong short-term momentum, up 9.9% recently.
Market Sentiment: SHPH scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$3.60 -
$5.07
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
41.2%
All Signals
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+9.9%)
- WARNING: Composite score 38/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.60 -
$5.07
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$3.30
Resistance Level
$5.68
Current Trend
Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Share & Embed Analysis
Last updated: October 23, 2026 3:21 PM ET
Data refreshes hourly during market hours. Next update: 4:21 PM
Data refreshes hourly during market hours. Next update: 4:21 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SHPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences IâĻ |
STRONG BUY
29 analysts |
$207 | 56 HOLD |
|
ELAN
Elanco Animal Health |
STRONG BUY
16 analysts |
$31 | 47 HOLD |
|
AQST
Aquestive Therapeutics IâĻ |
STRONG BUY
9 analysts |
$9 | 62 BUY |
|
ALKS
Alkermes Plc |
STRONG BUY
19 analysts |
$56 | 38 SELL |
|
AMLX
Amylyx Pharmaceuticals IâĻ |
STRONG BUY
12 analysts |
$43 | 54 HOLD |
